Astrazeneca PLC (
) will begin trading ex-dividend on February 19, 2014. A cash
dividend payment of $1.9 per share is scheduled to be paid on March
24, 2014. Shareholders who purchased AZN stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
represents an 111.11% increase over the prior quarter.
The previous trading day's last sale of AZN was $67.4,
representing a -0.88% decrease from the 52 week high of $68 and a
51.6% increase over the 52 week low of $44.46.
AZN is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). AZN's current earnings per share, an indicator of a company's
profitability, is $2.04. Zacks Investment Research reports AZN's
forecasted earnings growth in 2014 as -12.08%, compared to an
industry average of -.6%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to AZN through an Exchange
Traded Fund [ETF]?
The following ETF(s) have AZN as a top-10 holding:
- Merrill Lynch Pharmaceutical HOLDRS (
- FlexShares International Quality Dividend Index Fund (
- FlexShares International Quality Dividend Dynamic Index Fund
- FlexShares International Quality Dividend Defensive Index
- Guggenheim Defensive Equity ETF (
The top-performing ETF of this group is PPH with an increase of
16.92% over the last 100 days. It also has the highest percent
weighting of AZN at 4.72%.